Viracta Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.00-0.00-0.00-0.01
Price/Sales ratio
0.100.010.000.00
Earnings per Share (EPS)
$-1.15$-1.22$-1.13$-0.85

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-12.01-1.79-1.49-2.55-0.56-1.27-0.03-0.57-1.10-0.43-1.11-1.27
Price/Sales ratio
93.7121.4922.45135.5563.2214.325.39N/AN/AN/AN/A14.32
Price/Book Value ratio
38.932.402.704.203.751.07-0.011.230.901.200.891.07
Price/Cash Flow ratio
-12.44-1.69-1.54-2.50-0.61-1.33-0.04-6.17-1.55-0.55-1.54M-1.33
Price/Free Cash Flow ratio
-12.43-1.69-1.54-2.50-0.61-1.33-0.04-5.03-1.55-0.54-1.54M-1.33
Price/Earnings Growth ratio
-3.23-0.010.070.060.010.01-0.000.000.01N/A2.370.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%98.65%480.90%100%73.33%N/AN/AN/AN/A100%
Operating Profit Margin
-719.96%-1283.95%-1437.69%-5144.84%-10848.10%-1123.39%-15679.16%N/AN/AN/AN/A-10848.10%
Pretax Profit Margin
-749.94%-1198.17%-1499.32%-5300.14%-11229.95%-1125.42%-15847.5%N/AN/AN/AN/A-11229.95%
Net Profit Margin
-779.92%-1198.17%-1499.32%-5300.14%-11229.95%-1125.42%-15999.16%N/AN/AN/AN/A-11229.95%
Effective Tax Rate
-3.99%-2.56%-4.52%-3.93%-4.33%-2.20%-0.95%-76.94%-1.17%N/AN/A-4.33%
Return on Assets
-101.07%-78.03%-87.94%-103.27%-173.68%-62.64%-39.74%-187.06%-51.85%-90.06%-51.25%-173.68%
Return On Equity
-324.01%-133.88%-180.85%-164.58%-666.54%-84.70%41.55%-215.17%-81.45%-278.71%-67.50%-666.54%
Return on Capital Employed
-252.26%-140.34%-112.89%-158.93%-642.58%-83.69%-44.77%62.83%-58.83%-276.72%-58.83%-642.58%
Liquidity Ratios
Current Ratio
1.582.473.952.591.343.856.69N/AN/AN/A9.361.34
Quick Ratio
1.582.473.952.591.343.857.5111.589.451.439.091.34
Cash ratio
0.791.410.732.121.201.937.4911.393.670.323.671.20
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/A-1.58KN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A68.82K-563.22N/A17.75K5.94K4.41K1.81KN/A-563.22
Cash Conversion Cycle
N/AN/AN/A-68.82K563.22N/A-17.75KN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.200.160.330.200.480.160.100.050.260.450.360.36
Debt Equity Ratio
0.670.280.680.331.850.21-0.110.050.411.390.570.57
Long-term Debt to Capitalization
N/AN/A0.34N/AN/AN/A-0.090.050.28N/A0.28N/A
Total Debt to Capitalization
0.400.220.400.250.640.17-0.120.050.290.580.290.29
Interest Coverage Ratio
-26.20-41.85-21.18-24.65-22.27-45.30-73.85N/AN/AN/A-87.67-45.30
Cash Flow to Debt Ratio
-4.66-4.94-2.56-5.01-3.29-3.69-3.09-3.44-1.40-1.56-0.00-3.29
Company Equity Multiplier
3.201.712.051.593.831.35-1.041.151.573.091.571.57
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-7.53-12.65-14.57-54.02-102.97-10.70-133.78N/AN/AN/AN/A-102.97
Free Cash Flow / Operating Cash Flow Ratio
1.00111.00111.001.221.001.001.001
Cash Flow Coverage Ratio
-4.66-4.94-2.56-5.01-3.29-3.69-3.09-3.44-1.40-1.56-0.00-3.29
Short Term Coverage Ratio
-4.66-4.94-11.08-5.01-3.29-3.69-15.57-49.47-127.54-1.56-0.00-3.29
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A